Showing 1541-1550 of 23119 results for "".
Can Commoditization and Altruism of Organ Transplantation Coexist?
https://reachmd.com/programs/clinicians-roundtable/can-commoditization-and-altruism-of-organ-transplantation-coexist/3038/Dr. Benjamin Hippen speaks about the Iranian system that allows an individual's kidney to be sold by the donor, whom we can also think of as the vendor. Examination has shown that the recipients are on a level playing field and there is no tourism or fraud. The responsibility for recruiting potentiaManaging Per Capita Cost of Healthcare: The IHI's Triple Aim Project
https://reachmd.com/programs/clinicians-roundtable/triple-aim-managing-per-capita-cost-of-healthcare-the-ihis-triple-aim-project/2112/One of the components of the Institute for Healthcare Improvement's Triple Aim initiative is to manage the per capita cost of healthcare. Is this an achievable goal? How do we get there? In this segment Dr. John Whittington, lead faculty of the Triple Aim Project discusses healthcare cost managmentWar on Drugs: Myths of abuse and addiction
https://reachmd.com/programs/clinicians-roundtable/war-on-drugs-myths-of-abuse-and-addiction/1681/By all accounts, Winston Churchill was an alcoholic and yet he functioned at a very high level until the end of his long life. Yet does everyone who uses a potentially addictive substance become addicted? Our guest today is Dr. Berta Madras who serves as the Deputy Director of Demand ReductioMedical Animatics: Applications Within and Beyond Healthcare
https://reachmd.com/programs/clinicians-roundtable/medical-animatics-applications-within-and-beyond-healthcare/1262/Join Harlon Wilson, President and CEO of Medical Animatics, as he discusses the uses of cutting-edge 3-D modeling and animation for physicians, researchers, medical device companies, the pharmaceutical industry and the world of sports.CLINICAL IMPLICATIONS OF ASCT Research
https://reachmd.com/programs/clinicians-roundtable/clinical-implications-of-asct-research/1114/Tens of thousands of autologous stem cell transplants are performed each year to treat blood cancer. Is there a way to increase the long term success rates?Misconceptions of Embryonic Stem Cell Potential
https://reachmd.com/programs/clinicians-roundtable/misconceptions-of-embryonic-stem-cell-potential/965/In this segment, Dr. James Sherley explains relationship between stem cells and human organs. He proposes that the future of embryonic stem cells are mis-represented and will not ever be able to deliver upon the many promises made.Stem Cell Basics
https://reachmd.com/programs/clinicians-roundtable/stem-cell-basics/964/In this segment Dr. James Sherley offers physicians a review course on adult and embryonic stem cells.Certificate of Need Focused on Cardiology
https://reachmd.com/programs/clinicians-roundtable/certificate-of-need-focused-on-cardiology/102/Dr. Vivian Ho discusses regulations related to the Certificate of Need and its implications. Dr. Ho also reviews findings from a recent study published in Healthcare, Finance, and Economics.Evaluating a Lower-Intensity Treatment Regimen in AML: Phase 2 Results from PARADIGM
https://reachmd.com/programs/project-oncology/azacitidine-venetoclax-aml-phase-2-paradigm-trial/39973/At the 2025 American Society of Hematology Annual Meeting, researchers presented pivotal findings from the phase 2 PARADIGM trial on azacitidine and venetoclax in patients with acute myeloid leukemia (AML). In this AudioAbstract, Ryan Quigley shares key findings on how this lower-intensity regimen cAdditional Safey Data From TROPION-Breast02 and Study Design of TROPION-Breast06
https://reachmd.com/clinical-practice/oncology-hematology/additional-safey-data-from-tropion-breast02-and-study-design-of-tropion-breast06/49125/Learn how TROPION-Breast02 and TROPION-Breast06 are shaping the role of Dato-DXd in mTNBC and chemo-naïve HR+/HER2- mBC, respectively.